SCV
Sands Capital Ventures Portfolio holdings
AUM
$508M
This Quarter Return
+15.97%
1 Year Return
+48.12%
3 Year Return
+324.3%
5 Year Return
–
10 Year Return
–
AUM
$460M
AUM Growth
+$460M
(+29%)
Cap. Flow
+$108M
Cap. Flow
% of AUM
23.4%
Top 10 Holdings %
Top 10 Hldgs %
88.7%
Holding
22
New
2
Increased
7
Reduced
5
Closed
1
Top Buys
| 1 |
Inhibikase Therapeutics
IKT
|
$35.6M |
| 2 |
Coupang
CPNG
|
$20.1M |
| 3 |
Nu Holdings
NU
|
$15.8M |
| 4 |
Datadog
DDOG
|
$13.8M |
| 5 |
monday.com
MNDY
|
$11.4M |
Top Sells
| 1 |
Snowflake
SNOW
|
$10.7M |
| 2 |
DoorDash
DASH
|
$2.68M |
| 3 |
Klaviyo
KVYO
|
$1.84M |
| 4 |
BIOA
BioAge Labs, Inc. Common Stock
BIOA
|
$1.74M |
| 5 |
GitLab
GTLB
|
$33.9K |
Sector Composition
| 1 | Technology | 47.33% |
| 2 | Consumer Discretionary | 19.28% |
| 3 | Healthcare | 17.56% |
| 4 | Financials | 15.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Klaviyo
KVYO
$9.73B
| $143M | 31.13% |
3,470,694
-44,631
| -1% | -$1.84M |
|
|
2
Nu Holdings
NU
$71.5B
| $72.7M | 15.82% |
7,021,159
+1,522,357
| +28% | +$15.8M |
|
|
3
DoorDash
DASH
$105B
| $68.3M | 14.86% |
407,343
-15,995
| -4% | -$2.68M |
|
|
4
Inhibikase Therapeutics
IKT
$134M
| $35.6M | 7.74% |
+10,950,000
| New | +$35.6M |
|
|
5
Coupang
CPNG
$52.1B
| $20.3M | 4.42% |
924,712
+912,781
| +7,650% | +$20.1M |
|
6
UiPath
PATH
$5.95B
| $20.1M | 4.38% |
1,584,677
+429,431
| +37% | +$5.46M |
|
|
7
Datadog
DDOG
$47.7B
| $14M | 3.04% |
97,788
+96,382
| +6,855% | +$13.8M |
|
8
Acrivon Therapeutics
ACRV
$42.2M
| $12.8M | 2.78% |
2,122,605
| – | – |
|
|
9
monday.com
MNDY
$9.95B
| $11.4M | 2.47% |
+48,278
| New | +$11.4M |
|
10
Tarsus Pharmaceuticals
TARS
$2.47B
| $9.41M | 2.05% |
170,000
| – | – |
|
11
Samsara
IOT
$20.6B
| $8.68M | 1.89% |
198,690
+195,518
| +6,164% | +$8.54M |
|
12
Toast
TOST
$26.3B
| $8.44M | 1.84% |
231,530
+227,077
| +5,099% | +$8.28M |
|
13
10x Genomics
TXG
$1.74B
| $6.92M | 1.5% |
481,770
| – | – |
|
|
14
Snowflake
SNOW
$79.6B
| $6.02M | 1.31% |
39,007
-69,297
| -64% | -$10.7M |
|
15
Acumen Pharmaceuticals
ABOS
$82.4M
| $5.88M | 1.28% |
3,417,075
| – | – |
|
16
CrowdStrike
CRWD
$106B
| $5.85M | 1.27% |
17,100
+16,879
| +7,638% | +$5.78M |
|
|
BIOA
17
BioAge Labs, Inc. Common Stock
BIOA
$177M
| $4.55M | 0.99% |
786,353
-300,000
| -28% | -$1.74M |
|
18
Candel Therapeutics
CADL
$318M
| $3.52M | 0.77% |
405,837
| – | – |
|
19
Taysha Gene Therapies
TSHA
$797M
| $1.25M | 0.27% |
724,873
| – | – |
|
20
908 Devices
MASS
$226M
| $522K | 0.11% |
237,258
| – | – |
|
|
SPRB
21
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $301K | 0.07% |
715,817
-71,190
| -9% | -$29.9K |
|
|
22
GitLab
GTLB
$7.93B
| – | – |
-658
| Closed | -$33.9K |
|